Skip to main content

FATE

Fate Therapeutics Inc

Company with tickers: FATE

Market Cap
$245.36M
Shares Outstanding
116,559,186
CIK
1434316
CUSIP
31189P102
13F Activity (30d)
5 filings 4 filers
Investor Relations
Investor relations

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Repurchase History

Fiscal Year Ended Cash Spent
2014-03-31 $7,000
2013-12-31 $7,000
2011-12-31 $7,000